EditCo Bio, Inc. Unveils Novel Knockout CD4+ T-cell Pools to Transform Cancer and Autoimmune Research

REDWOOD CITY, Calif.--(BUSINESS WIRE)-- #AutoimmuneResearch--The addition of Knockout CD4+ T-cell Pools to EditCo Bio’s product lineup marks a significant leap forward in CRISPR-mediated gene editing.